Daily as of 3 Nov 16:00 ET
- Price
- above both $20.21 vs 50 $19.22 / 200 $15.81
- Projection
- No cross projected
- Test
- No active test
- Last cross
- ๐จGolden cross 13 Aug 2025 ยท projected 17 bars out
Amneal Pharmaceuticals, Inc. Class A (AMRX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.
The 50 SMA has sat above the 200 on the daily since Aug 2025, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits above the 50 and the 200; on the 4-hour it is between the two.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 16 Jun 2026 | ๐จGolden | 4-hour | 27 bars out | Not tested |
| 30 Mar 2026 | ๐Death | 4-hour | 30 bars out | 2 bar cross test |
| 13 Aug 2025 | ๐จGolden moderate | daily | 17 bars out | Not tested |
| 8 Jul 2025 | ๐จGolden | 4-hour | 29 bars out | โ |
| 21 Apr 2025 | ๐Death moderate | daily | 25 bars out | Not tested |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.